AVOQ, LLC

Lobbying for BIOTECHNOLOGY INNOVATION ORGANIZATION · â€‹Trade association.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $80,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Health Issues

General issues related to health care, including Most Favored Nation drug pricing; Issues related to FY27 Appropriations

Trade (domestic/foreign)

Issues related to international trade including tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.